Zeto Announces Expert Jury for Its EEG Clinical Trial Sponsorship Program

Zeto, Inc., an EEG brain monitoring company, has introduced the members of its jury panel for a new clinical trial sponsorship program. This panel consists of notable experts from neurology and neuroscience fields. It includes Robert Fisher, MD, PhD, Director of the Stanford Epilepsy Center and Michael Weisend, PhD, known for his work in cognitive neuroscience.

The jury will assess clinical trials that aim to improve biomedical research and patient care using innovative EEG applications. They will focus on projects aligning with Zeto's vision and expected to have significant patient care impacts. The selection of clinical trials will complete by June 1st, 2024, with an announcement expected by June 10th, 2024.